|
1
|
Shay J and Bacchetti S: A survey of
telomerase activity in human cancer. Eur J Cancer. 33:787–791.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mocellin S, Verdi D, Pooley KA, et al:
Telomerase reverse transcriptase locus polymorphisms and cancer
risk: a field synopsis and meta-analysis. J Natl Cancer Instit.
104:840–854. 2012. View Article : Google Scholar
|
|
3
|
Harley CB: Telomerase and cancer
therapeutics. Nat Rev Cancer. 8:167–179. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horikawa I and Barrett JC: Transcriptional
regulation of the telomerase hTERT gene as a target for cellular
and viral oncogenic mechanisms. Carcinogenesis. 24:1167–1176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nandakumar J and Cech TR: Finding the end:
recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol.
14:69–82. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baird DM: Variation at the TERT locus and
predisposition for cancer. Expert Rev Mol Med. 12:1–21. 2010.
View Article : Google Scholar
|
|
7
|
Rafnar T, Sulem P, Stacey SN, et al:
Sequence variants at the TERT-CLPTM1 L locus associate with many
cancer types. Nat Genet. 41:221–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
March-Villalba JA, Martínez-Jabaloyas JM,
Herrero MJ, Santamaría J, Aliño SF and Dasí F: Plasma hTERT mRNA
discriminates between clinically localized and locally advanced
disease and is a predictor of recurrence in prostate cancer
patients. Expert Opin Biol Ther. 12:69–77. 2012. View Article : Google Scholar
|
|
10
|
Heijnsdijk E, Der Kinderen A, Wever E,
Draisma G, Roobol M and De Koning H: Overdetection, overtreatment
and costs in prostate-specific antigen screening for prostate
cancer. Br J Cancer. 101:1833–1838. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng I, Plummer SJ, Neslund-Dudas C, et
al: Prostate cancer susceptibility variants confer increased risk
of disease progression. Cancer Epidemiol Biomarkers Prev.
19:2124–2132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
FitzGerald LM, Kwon EM, Conomos MP, et al:
Genome-wide association study identifies a genetic variant
associated with risk for more aggressive prostate cancer. Cancer
Epidemiol Biomarkers Prev. 20:1196–1203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sabaliauskaite R, Jarmalaite S, Petroska
D, et al: Combined analysis of TMPRSS2-ERG and TERT for improved
prognosis of biochemical recurrence in prostate cancer. Gene
Chromosome Canc. 51:781–791. 2012. View Article : Google Scholar
|
|
14
|
Iczkowski KA, Pantazis CG, McGregor DH, Wu
Y and Tawfik OW: Telomerase reverse transcriptase subunit
immunoreactivity. Cancer. 95:2487–2493. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gleason DF and Mellinger GT: Prediction of
prognosis for prostatic adenocarcinoma by combined histological
grading and clinical staging. J Urol. 111:58–64. 1974.PubMed/NCBI
|
|
16
|
D’Amico AV, Whittington R, Malkowicz SB,
et al: Biochemical outcome after radical prostatectomy, external
beam radiation therapy, or interstitial radiation therapy for
clinically localized prostate cancer. JAMA. 280:969–974. 1998.
View Article : Google Scholar
|
|
17
|
Purcell S, Neale B, Todd-Brown K, et al:
PLINK: a tool set for whole-genome association and population-based
linkage analyses. Am J Hum Gen. 81:559–575. 2007. View Article : Google Scholar
|
|
18
|
Witte JS: Prostate cancer genomics:
towards a new understanding. Nat Reviews Genet. 10:77–82. 2009.
View Article : Google Scholar
|
|
19
|
Wick M, Zubov D and Hagen G: Genomic
organization and promoter characterization of the gene encoding the
human telomerase reverse transcriptase (hTERT). Gene. 232:97–106.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang S, Wu J, Hu L, et al: Common genetic
variants in TERT contribute to risk of cervical cancer in a Chinese
population. Mol Carcinog. 51:E118–E122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar-Sinha C, Tomlins SA and Chinnaiyan
AM: Recurrent gene fusions in prostate cancer. Nat Rev Cancer.
8:497–511. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Landi MT, Chatterjee N, Yu K, et al: A
genome-wide association study of lung cancer identifies a region of
chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum
Gene. 85:679–691. 2009. View Article : Google Scholar
|
|
23
|
Taylor J, Tyekucheva S, King DC, Hardison
RC, Miller W and Chiaromonte F: ESPERR: learning strong and weak
signals in genomic sequence alignments to identify functional
elements. Genome Res. 16:1596–1604. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sheng X, Tong N, Tao G, et al: TERT
polymorphisms modify the risk of acute lymphoblastic leukemia in
Chinese children. Carcinogenesis. 34:228–235. 2013. View Article : Google Scholar
|
|
25
|
Willeit P, Willeit J, Mayr A, et al:
Telomere length and risk of incident cancer and cancer mortality.
JAMA. 304:69–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feldser DM, Hackett JA and Greider CW:
Telomere dysfunction and the initiation of genome instability. Nat
Rev Cancer. 3:623–627. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mirabello L, Huang WY, Wong JY, et al: The
association between leukocyte telomere length and cigarette
smoking, dietary and physical variables and risk of prostate
cancer. Aging cell. 8:405–413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma H, Zhou Z, Wei S, et al: Shortened
telomere length is associated with increased risk of cancer: a
meta-analysis. PLoS One. 6:e204662011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dong J, Wang L, Tian Y, Guo Y and Liu H:
hTERT single nucleotide polymorphism is associated with increased
risks of hepatocellular carcinoma and tumor metastasis. Nan Fang Yi
Ke Da Xue Xue Bao. 31:49–52. 2011.In Chinese. PubMed/NCBI
|
|
30
|
Bensen JT, Xu Z, Smith GJ, Mohler JL,
Fontham ET and Taylor JA: Genetic polymorphism and prostate cancer
aggressiveness: A case-only study of 1,536 GWAS and candidate SNPs
in African-Americans and European-Americans. Prostate. 73:11–22.
2013. View Article : Google Scholar
|
